Cannabis Use as Described by People with Multiple Sclerosis
Open Access
- 1 May 2003
- journal article
- research article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 30 (3), 201-205
- https://doi.org/10.1017/s0317167100002584
Abstract
Background: Multiple sclerosis (MS) is one of the most common neurological diseases affecting young adults. The prevalence of MS in Alberta has been described as among the highest reported in the world, estimated at 217 per 100,000. Numerous anecdotal reports, and a few small empirical investigations have suggested that cannabis use may relieve the symptom experience of those with MS. The present study was undertaken to describe cannabis use by this patient group. Information on peoples’beliefs, practices and experiences related to use were investigated. Methods: Aquestionnaire was mailed to a sample of 780 adults with MS in southern Alberta, Canada. Results: Completed questionnaires were returned by 420/673 eligible subjects (response rate 62%). Mean sample age was 48 years and 75% were women. Respondents ranged from mildly to severely impaired. The majority of respondents (96%) was aware cannabis was potentially therapeutically useful for MS and most (72%) supported legalization for medicinal purposes. Forty-three percent had tried cannabis at some point in their lives, 16% for medicinal purposes. Symptoms reported to be ameliorated included anxiety/depression, spasticity and chronic pain. Reasons given for not trying cannabis were the fact that it is an illegal substance, concern about side effects and lack of knowledge on how to obtain it. Conclusions: Subjective improvements in symptom experience were reported by the majority of people with MS who currently use cannabis. Further evaluation of this substance is warranted.Keywords
This publication has 22 references indexed in Scilit:
- Providing Medical Marijuana: The Importance of Cannabis ClubsJournal of Psychoactive Drugs, 1998
- Review of the AMA Council on Scientific Affairs Report on Medical MarijuanaJournal of Psychoactive Drugs, 1998
- Multiple Sclerosis: Symptomatic TherapiesSeminars in Neurology, 1998
- The Perceived Effects of Smoked Cannabis on Patients with Multiple SclerosisEuropean Neurology, 1997
- Analyzer Workshop on the Treatment of Parkinson's DiseaseEuropean Neurology, 1997
- Delta-9-THC in the Treatment of Spasticity Associated with Multiple SclerosisAdvances in Alcohol & Substance Abuse, 1988
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Tetrahydrocannabinol for tremor in multiple sclerosisAnnals of Neurology, 1983
- Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjectsPsychopharmacology, 1982
- Treatment of Human Spasticity with Δ9‐TetrahydrocannabinolThe Journal of Clinical Pharmacology, 1981